Targeting tumour-associated angiogenesis with zoledronate
The Chorioallantoic Membrane (CAM) assay can be used to assess a treatment's anti-angiogenic potential; but also, it can function as a tumour model in its own right. Tumourigenic cells are implanted in the embryo early in development, with these cells present before the development of the immun...
| Main Author: | |
|---|---|
| Published: |
University of Surrey
2012
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.583250 |